Format

Send to

Choose Destination
Diabetes Technol Ther. 2003;5(4):669-83.

Diabetes mellitus associated with atypical anti-psychotic medications.

Author information

1
Department of Medicine/Endocrinology, University Services, MSC10 5550, UNM HSC, University of New Mexico, Albuquerque, NM 87131, USA.

Abstract

Diabetes or hyperglycemia associated with the use of atypical anti-psychotic agents is a subject of growing concern among health care providers and the patients who use the drugs. Although much attention has been relegated to this topic in the mental health literature, there has been little attention devoted to it in the diabetes literature. The purpose of this report is to review the problem of diabetes mellitus associated with atypical anti-psychotic use from an endocrinology perspective. This paper will specifically present (a) a review of the increased prevalence of diabetes in the setting of schizophrenia, (b) a compilation and critical assessment of the existing publications that have documented the association of hyperglycemia and atypical anti-psychotic use, (c) a discussion of the potential mechanisms through which antipsychotics may lead to disturbances in glucose homeostasis, and (d) recommendations for the effective monitoring and treatment of affected patients.

PMID:
14511422
DOI:
10.1089/152091503322250695
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center